A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.
G. Cook, R.E. Clark, T Morris, M. Robertson, N.P. Lucie, S. Anderson, J. Paul, I.M. Franklin
Research output: Contribution to journal › Article › peer-review